Claritin Reditabs



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 46.0%
Hypersensitivity 12.9%
Medical Observation 7.1%
Rhinorrhoea 5.7%
Seasonal Allergy 5.7%
Sneezing 4.7%
Asthma 2.4%
Lacrimation Increased 2.4%
Rhinitis Allergic 2.2%
Hypertension 2.1%
Eye Pruritus 1.1%
Nasal Congestion 1.1%
Sinus Disorder 1.0%
Nasal Discomfort 0.9%
Thyroid Disorder 0.9%
Urticaria 0.9%
Diabetes Mellitus 0.7%
Drug Use For Unknown Indication 0.7%
Nasopharyngitis 0.7%
Throat Irritation 0.7%
Drug Ineffective 48.1%
Overdose 15.3%
Drug Effect Decreased 7.1%
Accidental Overdose 3.7%
Off Label Use 3.7%
Therapeutic Product Ineffective 3.7%
Somnolence 3.2%
Expired Drug Administered 2.6%
Feeling Abnormal 1.6%
Rash 1.6%
Oropharyngeal Pain 1.3%
Drug Ineffective For Unapproved Indication 1.1%
No Therapeutic Response 1.1%
Palpitations 1.1%
Arrhythmia 0.8%
Condition Aggravated 0.8%
Dizziness 0.8%
Fatigue 0.8%
Headache 0.8%
Insomnia 0.8%
Secondary
Product Used For Unknown Indication 28.2%
Hypersensitivity 12.4%
Medical Observation 10.6%
Rhinorrhoea 10.0%
Sneezing 9.7%
Lacrimation Increased 4.7%
Seasonal Allergy 3.7%
Asthma 3.4%
Eye Pruritus 2.9%
Hypertension 2.9%
Thyroid Disorder 1.5%
Upper-airway Cough Syndrome 1.4%
Blood Cholesterol 1.3%
Sinus Disorder 1.3%
Throat Irritation 1.3%
Dermatitis Atopic 1.1%
Glaucoma 1.1%
Blood Cholesterol Increased 1.0%
Nasal Discomfort 0.9%
Blood Pressure 0.8%
Drug Ineffective 36.6%
Overdose 19.6%
Therapeutic Product Ineffective 8.8%
Drug Effect Decreased 6.2%
Off Label Use 4.6%
Pruritus 3.1%
Somnolence 2.6%
Accidental Overdose 2.1%
Rash 2.1%
Drug Ineffective For Unapproved Indication 1.5%
Hypersensitivity 1.5%
Oropharyngeal Pain 1.5%
Petit Mal Epilepsy 1.5%
Product Packaging Issue 1.5%
Therapeutic Response Unexpected 1.5%
Drug Hypersensitivity 1.0%
Expired Drug Administered 1.0%
Fatigue 1.0%
Feeling Abnormal 1.0%
Head Discomfort 1.0%
Concomitant
Hepatitis C 26.0%
Hyperlipidaemia 17.0%
Chronic Hepatitis C 14.4%
Prophylaxis 8.9%
Iron Deficiency Anaemia 8.7%
Hypertension 4.1%
Product Used For Unknown Indication 3.2%
Constipation 2.3%
Drug Use For Unknown Indication 2.1%
Insomnia 2.0%
Gastric Ulcer 1.9%
Gastritis 1.7%
Asthma 1.4%
Depression 1.4%
Gastrooesophageal Reflux Disease 1.1%
Diabetes Mellitus 1.1%
Bronchitis 0.7%
Emphysema 0.7%
Pruritus 0.7%
Benign Prostatic Hyperplasia 0.6%
Anaemia 35.3%
Rash 22.1%
Renal Disorder 14.0%
Platelet Count Decreased 8.1%
Rash Papular 2.7%
Renal Impairment 2.7%
Pyelonephritis 2.3%
White Blood Cell Count Decreased 1.9%
Stevens-johnson Syndrome 1.6%
Hyperuricaemia 1.2%
Renal Failure 1.2%
Blood Potassium Abnormal 0.8%
Bronchitis 0.8%
Colorectal Cancer 0.8%
Drowning 0.8%
Gastroenteritis 0.8%
Hypoglycaemic Unconsciousness 0.8%
Loss Of Consciousness 0.8%
Pneumonia 0.8%
Presyncope 0.8%